SATS, via its wholly-owned subsidiary SATS Treasury, has established a US$3 billion ($4.03 billion) multicurrency debt issuance programme on Nov 17. The programme is unconditionally and irrevocably guaranteed by SATS.
Under the programme, SATS Treasury may issue notes and perpetual securities denominated in any currency that has been agreed upon with the relevant dealers and itself. Each series or tranche of notes may be issued in various amounts and tenors, and may bear interest at fixed rate, floating rate or zero coupon.
The notes will constitute direct, unconditional, unsubordinated and (subject to Condition 5(a) (negative pledge) of the notes) unsecured obligations of the Issuer and will at all times rank equally with all other present and future unconditional, unsubordinated and unsecured obligations of the SATS Treasury.
The securities have no fixed maturities and may be issued by SATS Treasury in various amounts. They may also bear fixed or floating rates of distribution, and if provided in the applicable pricing supplement, may have distributions deferred at the option of SATS Treasury. Senior securities and subordinated securities will also rank equally with SATS Treasury’s direct, unconditional, unsecured and subordinated obligations.
The net proceeds from the issue of the instruments under the programme will be used to refinance existing borrowings. They may also be used to finance potential acquisitions and investment opportunities for the company.
Moody’s has assigned an A3 issuer rating and a baa3 baseline credit assessment (BCA) to SATS. The programme has been assigned a provisional (P)A3 rating. The provisional rating is only applicable to the issuance of senior unsecured notes from the programme. The outlook on all ratings is stable.
See also: New IHH Healthcare CEO Nair lays out growth plans
DBS Bank and Oversea-Chinese Banking Corporation (OCBC) were the programme’s joint arrangers and dealers. OCBC acted as the sole rating advisor for the credit rating exercise.
Shares in SATS closed 2 cents lower or 0.73% down at $2.71 on Nov 17.
